Pacific Shuanglin Bio pharmacy Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 2.81%

Pacific Shuanglin Bio pharmacy Co Ltd (000403) has an Asset Resilience Ratio of 2.81% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Pacific Shuanglin Bio pharmacy Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥263.71 Million

≈ $38.59 Million USD Cash + Short-term Investments

Total Assets

CN¥9.38 Billion

≈ $1.37 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1996–2025)

This chart shows how Pacific Shuanglin Bio pharmacy Co Ltd's Asset Resilience Ratio has changed over time. See 000403 equity financing ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Pacific Shuanglin Bio pharmacy Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Pacific Shuanglin Bio pharmacy Co Ltd (000403) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥263.71 Million	2.81%
Total Liquid Assets	CN¥263.71 Million	2.81%

Asset Resilience Insights

Limited Liquidity: Pacific Shuanglin Bio pharmacy Co Ltd maintains only 2.81% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Pacific Shuanglin Bio pharmacy Co Ltd Industry Peers by Asset Resilience Ratio

Compare Pacific Shuanglin Bio pharmacy Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	84.34%
3SBio Inc F:83B	Biotechnology	10.64%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Jiangxi Fushine Pharmaceutical Co Ltd SHE:300497	Biotechnology	0.02%
Novavax Inc NASDAQ:NVAX	Biotechnology	53.87%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Pacific Shuanglin Bio pharmacy Co Ltd (1996–2025)

The table below shows the annual Asset Resilience Ratio data for Pacific Shuanglin Bio pharmacy Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	2.69%	CN¥254.39 Million ≈ $37.22 Million	CN¥9.47 Billion ≈ $1.39 Billion	-0.37pp
2024-12-31	3.06%	CN¥282.70 Million ≈ $41.37 Million	CN¥9.25 Billion ≈ $1.35 Billion	-1.85pp
2023-12-31	4.91%	CN¥423.34 Million ≈ $61.95 Million	CN¥8.63 Billion ≈ $1.26 Billion	-0.39pp
2022-12-31	5.29%	CN¥422.44 Million ≈ $61.82 Million	CN¥7.98 Billion ≈ $1.17 Billion	+1.99pp
2021-12-31	3.30%	CN¥234.21 Million ≈ $34.27 Million	CN¥7.09 Billion ≈ $1.04 Billion	+2.93pp
2017-12-31	0.38%	CN¥5.00 Million ≈ $731.66K	CN¥1.32 Billion ≈ $193.24 Million	+0.37pp
2010-12-31	0.01%	CN¥50.10K ≈ $7.33K	CN¥925.41 Million ≈ $135.42 Million	+0.00pp
2009-12-31	0.00%	CN¥47.45K ≈ $6.94K	CN¥1.25 Billion ≈ $183.18 Million	+0.00pp
2008-12-31	0.00%	CN¥28.10K ≈ $4.11K	CN¥1.21 Billion ≈ $177.76 Million	-0.10pp
2007-12-31	0.10%	CN¥1.69 Million ≈ $246.60K	CN¥1.66 Billion ≈ $242.84 Million	+0.07pp
2006-12-31	0.03%	CN¥566.03K ≈ $82.83K	CN¥1.71 Billion ≈ $249.56 Million	0.00pp
2005-12-31	0.03%	CN¥716.11K ≈ $104.79K	CN¥2.08 Billion ≈ $304.74 Million	-0.06pp
2004-12-31	0.10%	CN¥2.05 Million ≈ $300.28K	CN¥2.12 Billion ≈ $309.58 Million	-0.43pp
2003-12-31	0.53%	CN¥11.86 Million ≈ $1.74 Million	CN¥2.24 Billion ≈ $327.93 Million	+0.44pp
2002-12-31	0.09%	CN¥1.34 Million ≈ $196.17K	CN¥1.54 Billion ≈ $226.02 Million	-4.33pp
1996-12-31	4.42%	CN¥14.62 Million ≈ $2.14 Million	CN¥330.76 Million ≈ $48.40 Million	--

pp = percentage points

About Pacific Shuanglin Bio pharmacy Co Ltd

SHE:000403 China Biotechnology

Market Cap

$1.50 Billion

CN¥10.27 Billion CNY

Market Cap Rank

#7365 Global

#1700 in China

Share Price

CN¥10.81

Change (1 day)

-5.01%

52-Week Range

CN¥10.50 - CN¥18.89

All Time High

CN¥49.14